Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes

Hepatology

Volumn 28, Issue 1, 1998, Pages 237-244

  Fournillier, Anne ^a   Nakano, Isao ^a   Vitvitski, Ludmila ^a   Depla, Erik ^b   Vidalin, Olivier ^a   Maertens, Geert ^b   Trépo, Christian ^a   Inchauspé, Genevieve ^a  

^a INSERM   (France)

^b INNOGENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 4; PLASMID DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEROCONVERSION; VIRUS ENVELOPE;

ANIMALS; ANTIBODY FORMATION; BIOLISTICS; CYTOKINES; DNA, VIRAL; EPITOPES; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; IMMUNIZATION; INJECTIONS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PLASMIDS; SPLEEN; VIRAL ENVELOPE PROTEINS;

EID: 0031808288     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280131     Document Type: Article

References (7)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989;244:359-362.
2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redecker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
3. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-1479.
4. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990;87:6547-6549.
5. Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview. Semin Virol 1993;4:273-283.
6. Saito T, Shinzawa H, Kuboki M, Ishibashi M, Toda H, Okuyama Y, Nakamura T, et al. A randomized, controlled trial of human lymphoblastoid interferon in patients with compensated type C cirrhosis. Am J Gastroenterol 1994;89:681-686.
7. Abrignani S. Immune responses throughout hepatitis C virus (HCV) infection: HCV from rthe immune system point of view. Springer Semin Immunopathol 1997:19:47-55.